Cash & equivalents increased 87.2%
Cash & equivalents changed +87.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$17.8M→$33.3M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →AOUT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income increased 69.0%
Operating income changed +69.0% from the comparable as-filed period.
-$6.8M→-$2.1M2 prior comparisons
Gross margin moved 632 bp higher
Gross margin changed +632 basis points from the comparable as-filed period.
46.66%→52.97%2 prior comparisons
Operating margin moved 1728 bp higher
Operating margin changed +1728 basis points from the comparable as-filed period.
-22.96%→-5.68%2 prior comparisons
Net income increased 77.6%
Net income changed +77.6% from the comparable as-filed period.
-$6.8M→-$1.5M2 prior comparisons
Inventory / revenue moved 15423 bp lower
Inventory / revenue changed -15423 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
423.50%→269.27%2 prior comparisons
Revenue increased 25.4%
Revenue changed +25.4% from the comparable as-filed period.
$29.7M→$37.3M2 prior comparisons
Gross profit increased 42.4%
Gross profit changed +42.4% from the comparable as-filed period.
$13.9M→$19.7M2 prior comparisons
Free-cash-flow proxy changed across a sign change
Free-cash-flow proxy changed +749.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$2.0M→$12.9M2 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed +872.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$1.7M→$13.0M2 prior comparisons
Capital expenditure decreased 58.3%
Capital expenditure changed -58.3% from the comparable as-filed period.
$300,000→$125,0002 prior comparisons
Working capital / assets moved 544 bp higher
Working capital / assets changed +544 basis points from the comparable as-filed period.
52.75%→58.19%3 prior comparisons
Inventory decreased 20.3%
Inventory changed -20.3% from the comparable as-filed period.
$125.8M→$100.3M3 prior comparisons
Current liabilities decreased 19.8%
Current liabilities changed -19.8% from the comparable as-filed period.
$42.2M→$33.8M3 prior comparisons
Research & development decreased 20.6%
Research & development changed -20.6% from the comparable as-filed period.
$2.0M→$1.6M2 prior comparisons
Receivables / revenue moved 480 bp lower
Receivables / revenue changed -480 basis points from the comparable as-filed period.
73.24%→68.44%2 prior comparisons
Free-cash-flow margin moved 4136 bp higher
Free-cash-flow margin changed +4136 basis points from the comparable as-filed period.
-6.69%→34.66%2 prior comparisons
Operating cash-flow margin moved 4068 bp higher
Operating cash-flow margin changed +4068 basis points from the comparable as-filed period.
-5.68%→35.00%2 prior comparisons
Trade receivables increased 17.2%
Trade receivables changed +17.2% from the comparable as-filed period.
$21.8M→$25.5M3 prior comparisons
R&D / revenue moved 242 bp lower
R&D / revenue changed -242 basis points from the comparable as-filed period.
6.58%→4.17%2 prior comparisons
Capex / revenue moved 67 bp lower
Capex / revenue changed -67 basis points from the comparable as-filed period.
1.01%→0.34%2 prior comparisons
Current ratio increased 22.6%
Current ratio changed +22.6% from the comparable as-filed period.
4.02→4.933 prior comparisons
Stock-based compensation increased 13.2%
Stock-based compensation changed +13.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$651,000→$737,0002 prior comparisons
Total assets decreased 5.5%
Total assets changed -5.5% from the comparable as-filed period.
$241.9M→$228.6M3 prior comparisons
Shares outstanding decreased 0.2%
Shares outstanding changed -0.2% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
12,652,784→12,621,2258 prior comparisons
Stockholders' equity decreased 2.1%
Stockholders' equity changed -2.1% from the comparable as-filed period.
$167.8M→$164.4M2 prior comparisons
Working capital increased 4.3%
Working capital changed +4.3% from the comparable as-filed period.
$127.6M→$133.0M3 prior comparisons
Current assets decreased 1.7%
Current assets changed -1.7% from the comparable as-filed period.
$169.8M→$166.9M3 prior comparisons
SBC / revenue moved 21 bp lower
SBC / revenue changed -21 basis points from the comparable as-filed period.
2.19%→1.98%2 prior comparisons
Operating margin moved 743 bp lower
Operating margin changed -743 basis points from the comparable as-filed period.
0.52%→-6.92%1 prior comparisons
Gross margin moved 368 bp lower
Gross margin changed -368 basis points from the comparable as-filed period.
44.65%→40.97%1 prior comparisons
Cash & equivalents decreased 39.1%
Cash & equivalents changed -39.1% from the comparable as-filed period.
$17.1M→$10.4M2 prior comparisons
Research & development decreased 31.6%
Research & development changed -31.6% from the comparable as-filed period.
$1.9M→$1.3M1 prior comparisons
Inventory / revenue moved 314 bp lower
Inventory / revenue changed -314 basis points from the comparable as-filed period.
197.88%→194.74%1 prior comparisons
Operating income changed across a sign change
Operating income changed -1391.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$303,000→-$3.9M1 prior comparisons
Net income changed across a sign change
Net income changed -2510.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$169,000→-$4.1M1 prior comparisons
Revenue decreased 3.3%
Revenue changed -3.3% from the comparable as-filed period.
$58.5M→$56.6M1 prior comparisons
Gross profit decreased 11.3%
Gross profit changed -11.3% from the comparable as-filed period.
$26.1M→$23.2M1 prior comparisons
Inventory decreased 4.8%
Inventory changed -4.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$115.8M→$110.2M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.